UG1OD024943
Cooperative Agreement
Overview
Grant Description
Spectre: The Sunflower Pediatric Clinical Trials Research Extension
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Kansas City,
Kansas
66160
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/20 to 08/31/25 and the total obligations have increased 128% from $1,704,265 to $3,892,968.
University Of Kansas Medical Center Research Institute was awarded
SPeCTRE 2.0: The Sunflower Pediatric Clinical Trials Research Extension
Cooperative Agreement UG1OD024943
worth $3,892,968
from the National Institute of Allergy and Infectious Diseases in September 2016 with work to be completed primarily in Kansas City Kansas United States.
The grant
has a duration of 9 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required).
Status
(Ongoing)
Last Modified 1/28/25
Period of Performance
9/23/16
Start Date
8/31/25
End Date
Funding Split
$3.9M
Federal Obligation
$0.0
Non-Federal Obligation
$3.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UG1OD024943
Transaction History
Modifications to UG1OD024943
Additional Detail
Award ID FAIN
UG1OD024943
SAI Number
UG1OD024943-3959733399
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
YXJGGNC5J269
Awardee CAGE
3Q5T1
Performance District
KS-03
Senators
Jerry Moran
Roger Marshall
Roger Marshall
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,785,933 | 100% |
Modified: 1/28/25